Home » » Health Canada Directs Hoffmann-La Roche to Remove Use of Avastin (Bevacizumab) for the Treatment of Metastatic Breast Cancer from the Product Label

Health Canada Directs Hoffmann-La Roche to Remove Use of Avastin (Bevacizumab) for the Treatment of Metastatic Breast Cancer from the Product Label

Nov 28, 2011
Health Canada
http://www.marketwire.com/press-release/health-canada-directs-hoffmann-la-roche-remove-use-avastin-bevacizumab-treatment-metastatic-1591887.htm